Englund JA - Search Results

1

Duration of immunity against pertussis after natural infection or vaccination.

Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Wendelboe AM, et al. Among authors: englund ja. Pediatr Infect Dis J. 2005 May;24(5 Suppl):S58-61. doi: 10.1097/01.inf.0000160914.59160.41. Pediatr Infect Dis J. 2005. PMID: 15876927 Review.

2

Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination.

Rennels MB, Englund JA, Bernstein DI, Losonsky GA, Anderson EL, Pichichero ME, Munoz FM, Wolff MC. Rennels MB, et al. Among authors: englund ja. Pediatr Infect Dis J. 2000 May;19(5):417-23. doi: 10.1097/00006454-200005000-00006. Pediatr Infect Dis J. 2000. PMID: 10819337 Clinical Trial.

3

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.

Rennels MB, Deloria MA, Pichichero ME, Losonsky GA, Englund JA, Meade BD, Anderson EL, Steinhoff MC, Edwards KM. Rennels MB, et al. Among authors: englund ja. Pediatrics. 2000 Jan;105(1):e12. doi: 10.1542/peds.105.1.e12. Pediatrics. 2000. PMID: 10617749

4

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.

Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, Blackwelder WC, Jansen DL, Meade BD. Pichichero ME, et al. Among authors: englund ja. Pediatrics. 2000 Jan;105(1):e11. doi: 10.1542/peds.105.1.e11. Pediatrics. 2000. PMID: 10617748 Clinical Trial.

5

A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization.

Keitel WA, Muenz LR, Decker MD, Englund JA, Mink CM, Blumberg DA, Edwards KM. Keitel WA, et al. Among authors: englund ja. J Infect Dis. 1999 Aug;180(2):397-403. doi: 10.1086/314869. J Infect Dis. 1999. PMID: 10395855 Clinical Trial.

6

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.

Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD. Pichichero ME, et al. Among authors: englund ja. Pediatrics. 1997 Nov;100(5):772-88. doi: 10.1542/peds.100.5.772. Pediatrics. 1997. PMID: 9346976 Clinical Trial.

7

Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody.

Englund JA. Englund JA. Pediatr Infect Dis J. 1994 May;13(5):449-53. doi: 10.1097/00006454-199405000-00037. Pediatr Infect Dis J. 1994. PMID: 8072835 Review.

8

Controlled study of a new five-component acellular pertussis vaccine in adults and young children.

Englund JA, Glezen WP, Barreto L. Englund JA, et al. J Infect Dis. 1992 Dec;166(6):1436-41. doi: 10.1093/infdis/166.6.1436. J Infect Dis. 1992. PMID: 1431261 Clinical Trial.

9

Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations.

Tan T, Halperin S, Cherry JD, Edwards K, Englund JA, Glezen P, Greenberg D, Rothstein E, Skowronski D. Tan T, et al. Among authors: englund ja. Pediatr Infect Dis J. 2005 May;24(5 Suppl):S83-6. doi: 10.1097/01.inf.0000160919.94330.1a. Pediatr Infect Dis J. 2005. PMID: 15876933 Review.

10

Role of maternal pertussis antibodies in infants.

Van Rie A, Wendelboe AM, Englund JA. Van Rie A, et al. Among authors: englund ja. Pediatr Infect Dis J. 2005 May;24(5 Suppl):S62-5. doi: 10.1097/01.inf.0000160915.93979.8f. Pediatr Infect Dis J. 2005. PMID: 15876928 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results